Cleared Traditional

K902259 - AXIOM TOTAL KNEE SYSTEM

K902259 is an FDA 510(k) clearance for AXIOM TOTAL KNEE SYSTEM, manufactured by Orthomet, Inc.. The device is a Class 1 Microbiology device with product code JWX cleared through the Traditional 510(k) pathway after a 28-day FDA review.

K902259 · Orthomet, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1990
Decision
28d
Days
Class 1
Risk

K902259 is an FDA 510(k) clearance for the AXIOM TOTAL KNEE SYSTEM, TIBIAL COMPONENT. Classified as Kit, Screening, Staphylococcus Aureus (product code JWX), Class I - General Controls.

Submitted by Orthomet, Inc. (Minneapolis, US). The FDA issued a Cleared decision on June 18, 1990 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2660 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Orthomet, Inc. devices

FDA 510(k) Submission Details - K902259

510(k) Number K902259 FDA.gov
FDA Decision Cleared Substantially Equivalent - NSE Converted (SN)
Date Received May 21, 1990
Decision Date June 18, 1990
Days to Decision 28 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 102d · This submission: 28d
Pathway characteristics
Predicate-based equivalence.

JWX Device Classification - Class 1, General Controls

Product Code JWX Kit, Screening, Staphylococcus Aureus
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.2660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JWX Kit, Screening, Staphylococcus Aureus

All 10
Devices cleared under the same product code (JWX) and FDA review panel - the closest regulatory comparables to K902259.
STAPHYTECT PLUS/DRYSPOT STAPHYTECT PLUS
K972030 · Oxoid , Ltd. · Sep 1997
STAPH-A-LEX(TM) SYSTEM
K926173 · Trinity Laboratories, Inc. · Aug 1993
SLIDEX STAPH-KIT
K923212 · Biomerieux Vitek, Inc. · Sep 1992
NEG COMBO BREAKPOINT PANEL POS COMBO
K854278 · American Micro Scan · Mar 1986
V-TREND KIT STAPH LATEX TEST
K855220 · Texas Immunology, Inc. · Mar 1986
BACTO STAPHYLOCOCCUS LATEX TEST
K843560 · Difco Laboratories, Inc. · Oct 1984